跳至主要内容
临床试验/ACTRN12620000112965
ACTRN12620000112965已完成未知

Midline Catheters versus Peripherally Inserted Central Catheters: A randomised controlled trial to compare device failure outcomes for patients requiring prolonged intravenous therapy.

Griffith University0 个研究点目标入组 25 人开始时间: 2020年2月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Informed consent to participate
  • The treating team have referred the patient to receive a PICC with peripherally-compatible intravenous therapy
  • Patient expected to receive IV therapy for up to or equal to 29 days
  • The treating team has approved the use of either a MC or PICC.

排除标准

  • Non-English speakers without interpreter
  • Patient receiving end-of-life care
  • Patient with a history of venous thromboembolism or renal disease
  • Cognitive barrier to consent (without a SDM)
  • Previous enrolment in this study
  • Patient receiving chemotherapy treatment
  • Patient lives outside Metro North Hospital and Health Service.
  • History of intravenous drug use in the last one year

研究者

相似试验

COmparing the use of Midline Catheters versus... | 临床试验